Efficacy of AST-120 for Patients With Chronic Kidney Disease: A Network Meta-Analysis of Randomized Controlled Trials
AST-120, an oral spherical activated carbon, may delay the need for kidney dialysis and improve uremia symptoms because it can adsorb acidic and basic organic compounds, especially small-molecule uremic toxins. However, previous studies produced no conclusive evidence regarding the benefits of AST-1...
Saved in:
Main Authors: | Pei-Yu Su (Author), Ya-Han Lee (Author), Li-Na Kuo (Author), Yen-Cheng Chen (Author), Chiehfeng Chen (Author), Yi-No Kang (Author), Elizabeth H. Chang (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comment on: "Effect of vitamin D monotherapy on indices of sarcopenia in community‐dwelling older adults: a systematic review and meta‐analysis" by Prokopidis et al.
by: Shih‐Hao Cheng, et al.
Published: (2022) -
Exploring the efficacy of using hypertonic saline for nebulizing treatment in children with bronchiolitis: a meta-analysis of randomized controlled trials
by: Chia-Wen Hsieh, et al.
Published: (2020) -
Effects of AST‐120 on muscle health and quality of life in chronic kidney disease patients: results of RECOVERY study
by: Ran‐hui Cha, et al.
Published: (2022) -
BNT162b2 immunization-related myocarditis in adolescents and consequent hospitalization: Report from a medical center
by: Chen-Wei Yen, et al.
Published: (2023) -
Perceptions of ChatGPT in healthcare: usefulness, trust, and risk
by: Su-Yen Chen, et al.
Published: (2024)